Role of inflammasome activation in tumor immunity triggered by immune checkpoint blockers
Authors:
Open Access
- 16 April 2020
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 200 (2) , 155-162
Abstract
Summary: Immune checkpoint blockers improve the overall survival of a limited number of patients among different cancers. Identifying pathways that influence the immunological and clinical response to treatment is critical to improve the therapeutic efficacy and predict clinical responses. Recently, a key role has been assigned to innate immune mechanisms in checkpoint blockade-driven anti-tumor responses. However, inflammatory pathways can both improve and impair anti-tumor immunity. In this review, we discuss how different inflammatory pathways, particularly inflammasome activation, can influence the clinical outcome of immune checkpoint blockers. Inflammasome activation may reinforce anti-tumor immunity by boosting CD8+ T cell priming as well as by enhancing T helper type 17 (Th17) responses. In particular, we focus on the modulation of the cation channel transmembrane protein 176B (TMEM176B) and the ectonucleotidase CD39 as potential targets to unleash inflammasome activation leading to reinforced anti-tumor immunity and improved efficacy of immune checkpoint blockers. Future studies should be aimed at investigating the mechanisms and cell subsets involved in inflammasome-driven anti-tumor responses.Keywords
Funding Information
- Agencia Nacional de Investigación e Innovación (FMV_1_2017_1_136177)
- Agencia Nacional de Promoción Científica y Tecnológica (2017-0494)
This publication has 97 references indexed in Scilit:
- Molecular definition of the identity and activation of natural killer cellsNature Immunology, 2012
- Interleukin-1R Signaling Is Essential for Induction of Proapoptotic CD8 T Cells, Viral Clearance, and Pathology during Lymphocytic Choriomeningitis Virus Infection in MiceJournal of Virology, 2012
- Critical role for calcium mobilization in activation of the NLRP3 inflammasomeProceedings of the National Academy of Sciences, 2012
- Expression of CD39 by Human Peripheral Blood CD4+CD25+ T Cells Denotes a Regulatory Memory PhenotypeAmerican Journal of Transplantation, 2010
- Generation of pathogenic TH17 cells in the absence of TGF-β signallingNature, 2010
- Immunity, Inflammation, and CancerCell, 2010
- T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor ImmunityImmunity, 2009
- Isolated CD39 Expression on CD4+ T Cells Denotes both Regulatory and Memory PopulationsAmerican Journal of Transplantation, 2009
- Inflammasome recognition of influenza virus is essential for adaptive immune responsesJournal of Experimental Medicine, 2009
- Membrane proteomics of phagosomes suggests a connection to autophagyProceedings of the National Academy of Sciences, 2008